Saturday 6 March 2021
Home      All news      Contact us      RSS     
healtheuropa - 1 month ago

Novavax COVID-19 vaccine shows efficacy against Kent variant

Novavax has released data from its phase III COVID-19 vaccine candidate study that demonstrates it as effective against the Kent variant of the virus. Conducted during the period when the Kent COVID-19 variant was first observed, the phase III trial has shown the vaccine to be 89.3% effective in preventing coronavirus in participants, as well [ ] The post Novavax COVID-19 vaccine shows efficacy against Kent variant appeared first on Health Europa.


Latest News
Hashtags:   

Novavax

 | 

COVID

 | 

vaccine

 | 

shows

 | 

efficacy

 | 

against

 | 

variant

 | 

Sources